FDA Approves NatureCell's Adult Autism Stem Cell Therapy for Clinical Trials

Biotech firm's 'AstroStem-AU' therapy to begin Phase 1 testing, advancing RMAT and accelerated approval pathways.

Apr. 15, 2026 at 5:40pm

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray image of a human brain, with glowing neural pathways and structures, conceptually representing the potential for stem cell therapies to address neurological conditions like autism.Stem cell therapy offers new hope for treating the neurological complexities of adult autism.Los Angeles Today

NatureCell Co., Ltd., a biotechnology company focused on adult stem cell therapies, has received FDA approval to initiate Phase 1 clinical trials for its 'AstroStem-AU' therapy targeting adult autism. This IND clearance represents a pivotal step toward developing a treatment for the condition.

Why it matters

The approval of NatureCell's adult autism stem cell therapy for clinical trials is a significant milestone in the search for new treatments for this complex neurological disorder. If successful, AstroStem-AU could provide a much-needed therapeutic option for the adult autism community.

The details

NatureCell's AstroStem-AU therapy utilizes the company's proprietary adult stem cell technology to target the core symptoms of autism in adults. The FDA's IND approval allows NatureCell to begin Phase 1 safety and tolerability trials, a crucial step toward potential RMAT (Regenerative Medicine Advanced Therapy) designation and accelerated approval pathways.

  • NatureCell received FDA IND approval on April 15, 2026.
  • The company will now initiate Phase 1 clinical trials for AstroStem-AU.

The players

NatureCell Co., Ltd.

A biotechnology company focused on developing adult stem cell therapies, led by Chairman Jeong-chan Ra.

Got photos? Submit your photos here. ›

What’s next

The successful completion of Phase 1 trials will allow NatureCell to advance AstroStem-AU toward larger Phase 2 and Phase 3 studies, potentially leading to RMAT designation and accelerated approval from the FDA.

The takeaway

The FDA's approval of NatureCell's adult autism stem cell therapy for clinical trials is a significant breakthrough in the search for new treatments for this complex condition. If proven safe and effective, AstroStem-AU could provide hope and improved quality of life for the adult autism community.